Click on the links to read the full interview:
![](https://vision-dmd.info/vision1/wp-content/uploads/2020/07/Laurie-pic.jpg)
Dr Laurie Conklin -Vice President, Medical and Regulatory Affairs of ReveraGen Biopharma
Designed to ensure a timely & cost-effective drug development for Duchenne muscular dystrophy
Click on the links to read the full interview:
Dr Laurie Conklin -Vice President, Medical and Regulatory Affairs of ReveraGen Biopharma
Multilingual WordPress with WPML